In this cohort study involving a combined 15 928 individuals, findings suggested that certain high-risk criteria may improve the identification of individuals at higher risk of progression to severe AUD. Defining severe AUD vulnerability using these criteria is consistent with extant etiological and clinical insight and may improve treatment penetrance.
